Mochida Pharmaceutical Co Ltd (4534.T) announced earnings for its full year that Increased, from last year
The company's bottom line totaled JPY7.903 billion, or JPY222.96 per share. This compares with JPY5.685 billion, or JPY160.36 per share, last year.
The company's revenue for the period rose 11.2% to JPY116.951 billion from JPY105.159 billion last year.
Mochida Pharmaceutical Co Ltd earnings at a glance (GAAP) :
-Earnings: JPY7.903 Bln. vs. JPY5.685 Bln. last year.-EPS: JPY222.96 vs. JPY160.36 last year.-Revenue: JPY116.951 Bln vs. JPY105.159 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.